1. Clinical use of the co‐formulation of insulin degludec and insulin aspart. Issue 8 (7th July 2016) Authors: Kumar, A.; Awata, T.; Bain, S. C.; Ceriello, A.; Fulcher, G. R.; Unnikrishnan, A. G.; Arechavaleta, R.; Gonzalez‐Gálvez, G.; Hirose, T.; Home, P. D.; Kaku, K.; Litwak, L.; Madsbad, S.; Pinget, M.; Mehta, R.; Mithal, A.; Tambascia, M.; Tibaldi, J.; Christiansen, J.S. Journal: International journal of clinical practice Issue: Volume 70:Issue 8(2016) Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Distal transfers as a primary treatment in obstetric brachial plexus palsy: a series of 20 cases. (October 2016) Authors: Ghanghurde, B. A.; Mehta, R.; Ladkat, K. M.; Raut, B. B.; Thatte, M. R. Journal: Journal of hand surgery Issue: Volume 41:Number 8(2016:Oct.) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of chronic deoxynivalenol exposure on p53 heterozygous and p53 homozygous mice. (October 2016) Authors: Bondy, G.S.; Coady, L.; Curran, I.; Caldwell, D.; Armstrong, C.; Aziz, S.A.; Nunnikhoven, A.; Gannon, A.M.; Liston, V.; Shenton, J.; Mehta, R. Journal: Food and chemical toxicology Issue: Volume 96(2016) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B. Issue 9 (15th September 2016) Authors: Marcellin, P.; Ahn, S. H.; Chuang, W.‐L.; Hui, A. J.; Tabak, F.; Mehta, R.; Petersen, J.; Lee, C.‐M.; Ma, X.; Caruntu, F. A.; Tak, W. Y.; Elkhashab, M.; Lin, L.; Wu, G.; Martins, E. B; Charuworn, P.; Yee, L. J.; Lim, S. G.; Foster, G. R.; Fung, S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 9(2016) Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Sofosbuvir plus ribavirin in treatment‐naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India. Issue 5 (9th December 2016) Authors: Shah, S. R.; Chowdhury, A.; Mehta, R.; Kapoor, D.; Duseja, A.; Koshy, A.; Shukla, A.; Sood, A.; Madan, K.; Sud, R.; Nijhawan, S.; Pawan, R.; Prasad, M.; Kersey, K.; Jiang, D.; Svarovskaia, E.; Doehle, B.; Kanwar, B.; Subramanian, M.; Acharya, S. K. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 5(2017) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗